NCT00535119 Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer Status COMPLETED Phase PHASE1
NCT00533949 High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE3
NCT00533585 BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT00533429 Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT00529503 A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL Status TERMINATED Phase PHASE2
NCT00529022 Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00527735 Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE2
NCT00526890 Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT00526318 Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma Status UNKNOWN Phase NA
NCT00520975 Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Status TERMINATED Phase PHASE3
NCT00520676 Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00520013 Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Status COMPLETED Phase PHASE2
NCT00520000 Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00517361 Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00516724 Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel Status COMPLETED Phase PHASE1
NCT00514540 Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00514293 Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00513786 Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma Status COMPLETED Phase PHASE2
NCT00513383 Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck Status COMPLETED Phase PHASE1